JESSE I TREU Insider Trading $OREX Orexigen Therapeutics, Inc.
Get free email notifications about insider trading for JESSE I TREU.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JESSE I TREU. JESSE I TREU is 10% Owner in SENOMYX INC ($SNMX) and 10% Owner in INTRALASE CORP ($ILSE) and 10% Owner in Paratek Pharmaceuticals, Inc. ($PRTK) and 10% Owner in SANTARUS INC ($SNTS) and 10% Owner in NUVASIVE INC ($NUVA) and 10% Owner in ALIMERA SCIENCES INC ($ALIM) and 10% Owner in Ocera Therapeutics, Inc. ($TZYM) and Director in Northstar Neuroscience, Inc. ($NSTR) and 10% Owner in ACHILLION PHARMACEUTICALS INC ($ACHN) and 10% Owner in Achaogen Inc ($AKAO) and Director in Tobira Therapeutics, Inc. ($TBRA) and 10% Owner in CADENCE PHARMACEUTICALS INC ($CADX) and Director in SENORX INC ($SENO) and Director in Pernix Sleep, Inc. ($SOMX) and Director in CoLucid Pharmaceuticals, Inc. ($CLCD) and 10% Owner in INTERCELL USA, INC. ($IOMI) and Director in Aldeyra Therapeutics, Inc. ($ALDX) and 10% Owner in Vanda Pharmaceuticals Inc. ($VNDA) and 10% Owner in Volcano Corp ($VOLC) and 10% Owner in ZOGENIX, INC. ($ZGNX) and Director in VERACYTE, INC. ($VCYT) and 10% Owner in Orexigen Therapeutics, Inc. ($OREX) and 10% Owner in Dicerna Pharmaceuticals Inc ($DRNA) and 10% Owner in Evoke Pharma Inc ($EVOK) and 10% Owner in Esperion Therapeutics, Inc. ($ESPR) and Director in TANDEM DIABETES CARE INC ($TNDM) and 10% Owner in Clovis Oncology, Inc. ($CLVS) and 10% Owner in REVA Medical, Inc. ($RVA) and 10% Owner in Durata Therapeutics, Inc. ($DRTX).
JESSE I TREU in Orexigen Therapeutics, Inc.
Trading Symbol: OREXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JESSE I TREU: 10% Owner
Holdings: 50,643 shares
Current Value: $231,945
Latest Transaction: Dec 22 2011
$OREX Market Capitalization: $70.30M
$OREX Previous Close: $4.58
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JESSE I TREU in Orexigen Therapeutics, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AKAO, ACHN, ALDX, ALIM, CADX, CLVS, CLCD, DRNA, DRTX, ESPR, EVOK, IOMI, ILSE, NSTR, NUVA, TZYM, OREX, PRTK, SOMX, RVA, SNTS, SNMX, SENO, TNDM, TBRA, VNDA, VCYT, VOLC, ZGNX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 22 2011 | OREX | Orexigen Therapeut ... | TREU JESSE I | 10% Owner | Option Exercise | P | 0.00 | 7,882 | 8 | 7,882 | |
Dec 22 2011 | OREX | Orexigen Therapeut ... | TREU JESSE I | 10% Owner | Option Exercise | P | 0.00 | 461,265 | 461 | 461,265 | |
Dec 22 2011 | OREX | Orexigen Therapeut ... | TREU JESSE I | 10% Owner | Buy | P | 1.45 | 7,882 | 11,429 | 50,643 | 42.8 K to 50.6 K (+18.43 %) |
Dec 22 2011 | OREX | Orexigen Therapeut ... | TREU JESSE I | 10% Owner | Buy | P | 1.45 | 461,265 | 668,834 | 2,967,415 | 2.5 M to 3 M (+18.41 %) |
Dec 21 2009 | OREX | Orexigen Therapeut ... | TREU JESSE I | 10% Owner | Buy | P | 7.50 | 639 | 4,793 | 42,761 | 42.1 K to 42.8 K (+1.52 %) |
Dec 21 2009 | OREX | Orexigen Therapeut ... | TREU JESSE I | 10% Owner | Buy | P | 7.50 | 37,461 | 280,958 | 2,506,150 | 2.5 M to 2.5 M (+1.52 %) |
Dec 21 2009 | OREX | Orexigen Therapeut ... | TREU JESSE I | 10% Owner | Buy | P | 7.55 | 1,677 | 12,661 | 42,122 | 40.4 K to 42.1 K (+4.15 %) |
Dec 21 2009 | OREX | Orexigen Therapeut ... | TREU JESSE I | 10% Owner | Buy | P | 7.55 | 98,323 | 742,339 | 2,468,689 | 2.4 M to 2.5 M (+4.15 %) |
Nov 25 2009 | OREX | Orexigen Therapeut ... | TREU JESSE I | 10% Owner | Buy | P | 6.75 | 839 | 5,663 | 40,445 | 39.6 K to 40.4 K (+2.12 %) |
Nov 25 2009 | OREX | Orexigen Therapeut ... | TREU JESSE I | 10% Owner | Buy | P | 6.75 | 49,161 | 331,837 | 2,370,366 | 2.3 M to 2.4 M (+2.12 %) |
Nov 24 2009 | OREX | Orexigen Therapeut ... | TREU JESSE I | 10% Owner | Buy | P | 6.93 | 2,516 | 17,436 | 39,606 | 37.1 K to 39.6 K (+6.78 %) |
Nov 24 2009 | OREX | Orexigen Therapeut ... | TREU JESSE I | 10% Owner | Buy | P | 6.93 | 147,484 | 1,022,064 | 2,321,205 | 2.2 M to 2.3 M (+6.78 %) |
Nov 24 2009 | OREX | Orexigen Therapeut ... | TREU JESSE I | 10% Owner | Buy | P | 6.93 | 4,192 | 29,051 | 37,090 | 32.9 K to 37.1 K (+12.74 %) |
Nov 24 2009 | OREX | Orexigen Therapeut ... | TREU JESSE I | 10% Owner | Buy | P | 6.93 | 245,808 | 1,703,449 | 2,173,721 | 1.9 M to 2.2 M (+12.75 %) |
Nov 16 2009 | OREX | Orexigen Therapeut ... | TREU JESSE I | 10% Owner | Buy | P | 6.90 | 1,040 | 7,176 | 32,898 | 31.9 K to 32.9 K (+3.26 %) |
Nov 16 2009 | OREX | Orexigen Therapeut ... | TREU JESSE I | 10% Owner | Buy | P | 6.90 | 60,960 | 420,624 | 1,927,913 | 1.9 M to 1.9 M (+3.27 %) |
Nov 12 2009 | OREX | Orexigen Therapeut ... | TREU JESSE I | 10% Owner | Buy | P | 6.93 | 899 | 6,230 | 31,858 | 31 K to 31.9 K (+2.90 %) |
Nov 12 2009 | OREX | Orexigen Therapeut ... | TREU JESSE I | 10% Owner | Buy | P | 6.93 | 52,701 | 365,218 | 1,866,953 | 1.8 M to 1.9 M (+2.90 %) |
Nov 12 2009 | OREX | Orexigen Therapeut ... | TREU JESSE I | 10% Owner | Buy | P | 6.93 | 1,415 | 9,806 | 30,959 | 29.5 K to 31 K (+4.79 %) |
Nov 12 2009 | OREX | Orexigen Therapeut ... | TREU JESSE I | 10% Owner | Buy | P | 6.93 | 82,985 | 575,086 | 1,814,252 | 1.7 M to 1.8 M (+4.79 %) |
Aug 19 2009 | OREX | Orexigen Therapeut ... | TREU JESSE I | 10% Owner | Buy | P | 7.73 | 231 | 1,786 | 29,544 | 29.3 K to 29.5 K (+0.79 %) |
Aug 19 2009 | OREX | Orexigen Therapeut ... | TREU JESSE I | 10% Owner | Buy | P | 7.73 | 13,553 | 104,765 | 1,731,267 | 1.7 M to 1.7 M (+0.79 %) |
Aug 18 2009 | OREX | Orexigen Therapeut ... | TREU JESSE I | 10% Owner | Buy | P | 7.64 | 1,060 | 8,098 | 29,313 | 28.3 K to 29.3 K (+3.75 %) |
Aug 18 2009 | OREX | Orexigen Therapeut ... | TREU JESSE I | 10% Owner | Buy | P | 7.64 | 62,141 | 474,757 | 1,717,714 | 1.7 M to 1.7 M (+3.75 %) |
Aug 18 2009 | OREX | Orexigen Therapeut ... | TREU JESSE I | 10% Owner | Buy | P | 8.00 | 440 | 3,520 | 28,253 | 27.8 K to 28.3 K (+1.58 %) |
Aug 18 2009 | OREX | Orexigen Therapeut ... | TREU JESSE I | 10% Owner | Buy | P | 8.00 | 25,785 | 206,280 | 1,655,573 | 1.6 M to 1.7 M (+1.58 %) |
Aug 14 2009 | OREX | Orexigen Therapeut ... | TREU JESSE I | 10% Owner | Buy | P | 7.85 | 218 | 1,711 | 27,813 | 27.6 K to 27.8 K (+0.79 %) |
Aug 14 2009 | OREX | Orexigen Therapeut ... | TREU JESSE I | 10% Owner | Buy | P | 7.85 | 12,782 | 100,339 | 1,629,788 | 1.6 M to 1.6 M (+0.79 %) |
Aug 14 2009 | OREX | Orexigen Therapeut ... | TREU JESSE I | 10% Owner | Buy | P | 8.00 | 6,708 | 53,664 | 27,595 | 20.9 K to 27.6 K (+32.12 %) |
Aug 14 2009 | OREX | Orexigen Therapeut ... | TREU JESSE I | 10% Owner | Buy | P | 8.00 | 393,292 | 3,146,336 | 1,617,006 | 1.2 M to 1.6 M (+32.14 %) |
Aug 13 2009 | OREX | Orexigen Therapeut ... | TREU JESSE I | 10% Owner | Buy | P | 7.60 | 1,749 | 13,292 | 20,887 | 19.1 K to 20.9 K (+9.14 %) |
Aug 13 2009 | OREX | Orexigen Therapeut ... | TREU JESSE I | 10% Owner | Buy | P | 7.60 | 102,551 | 779,388 | 1,223,714 | 1.1 M to 1.2 M (+9.15 %) |
Aug 13 2009 | OREX | Orexigen Therapeut ... | TREU JESSE I | 10% Owner | Buy | P | 7.60 | 1,749 | 13,292 | 20,887 | 19.1 K to 20.9 K (+9.14 %) |
Aug 13 2009 | OREX | Orexigen Therapeut ... | TREU JESSE I | 10% Owner | Buy | P | 7.60 | 102,551 | 779,388 | 1,223,714 | 1.1 M to 1.2 M (+9.15 %) |
Jul 24 2009 | OREX | Orexigen Therapeut ... | TREU JESSE I | 10% Owner | Buy | P | 7.50 | 10,901 | 81,758 | 19,138 | 8.2 K to 19.1 K (+132.34 %) |
Jul 24 2009 | OREX | Orexigen Therapeut ... | TREU JESSE I | 10% Owner | Buy | P | 7.50 | 639,099 | 4,793,243 | 1,121,163 | 482.1 K to 1.1 M (+132.58 %) |
Dec 10 2008 | OREX | Orexigen Therapeut ... | TREU JESSE I | 10% Owner | Buy | P | 4.93 | 4,064 | 20,036 | 8,237 | 4.2 K to 8.2 K (+97.39 %) |
Dec 10 2008 | OREX | Orexigen Therapeut ... | TREU JESSE I | 10% Owner | Buy | P | 4.93 | 237,826 | 1,172,482 | 482,064 | 244.2 K to 482.1 K (+97.37 %) |
Dec 10 2008 | OREX | Orexigen Therapeut ... | TREU JESSE I | 10% Owner | Buy | P | 4.47 | 4,173 | 18,653 | 4,173 | 0 to 4.2 K |
Dec 10 2008 | OREX | Orexigen Therapeut ... | TREU JESSE I | 10% Owner | Buy | P | 4.47 | 244,238 | 1,091,744 | 244,238 | 0 to 244.2 K |
May 01 2007 | OREX | Orexigen Therapeut ... | TREU JESSE I | 10% Owner | Option Exercise | C | 0.00 | 21,076 | 0 | 0 | |
May 01 2007 | OREX | Orexigen Therapeut ... | TREU JESSE I | 10% Owner | Option Exercise | C | 0.00 | 892,192 | 0 | 0 | |
May 01 2007 | OREX | Orexigen Therapeut ... | TREU JESSE I | 10% Owner | Option Exercise | C | 0.00 | 26,669 | 0 | 0 | |
May 01 2007 | OREX | Orexigen Therapeut ... | TREU JESSE I | 10% Owner | Option Exercise | C | 0.00 | 1,128,955 | 0 | 0 | |
May 01 2007 | OREX | Orexigen Therapeut ... | TREU JESSE I | 10% Owner | Option Exercise | C | 0.00 | 39,114 | 0 | 0 | |
May 01 2007 | OREX | Orexigen Therapeut ... | TREU JESSE I | 10% Owner | Option Exercise | C | 0.00 | 1,655,801 | 0 | 0 | |
May 01 2007 | OREX | Orexigen Therapeut ... | TREU JESSE I | 10% Owner | Buy | P | 12.00 | 12,116 | 145,392 | 104,975 | 92.9 K to 105 K (+13.05 %) |
May 01 2007 | OREX | Orexigen Therapeut ... | TREU JESSE I | 10% Owner | Buy | P | 12.00 | 512,884 | 6,154,608 | 4,443,832 | 3.9 M to 4.4 M (+13.05 %) |
May 01 2007 | OREX | Orexigen Therapeut ... | TREU JESSE I | 10% Owner | Buy | C | 0.00 | 86,859 | 0 | 92,859 | 6 K to 92.9 K (+1,447.65 %) |
May 01 2007 | OREX | Orexigen Therapeut ... | TREU JESSE I | 10% Owner | Buy | C | 0.00 | 3,676,948 | 0 | 3,930,948 | 254 K to 3.9 M (+1,447.62 %) |
Page: 1